Edward Raby

938 total citations
43 papers, 539 citations indexed

About

Edward Raby is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Edward Raby has authored 43 papers receiving a total of 539 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Infectious Diseases, 10 papers in Epidemiology and 9 papers in Molecular Biology. Recurrent topics in Edward Raby's work include Antimicrobial Resistance in Staphylococcus (7 papers), Bacterial Identification and Susceptibility Testing (7 papers) and Streptococcal Infections and Treatments (6 papers). Edward Raby is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (7 papers), Bacterial Identification and Susceptibility Testing (7 papers) and Streptococcal Infections and Treatments (6 papers). Edward Raby collaborates with scholars based in Australia, United Kingdom and Colombia. Edward Raby's co-authors include Maureen Moyo, Peter Godfrey‐Faussett, Petra de Haas, Helen Ayles, Joseph Banda, Jeremy K. Nicholson, Elaine Holmes, Laurens Manning, John R. Dyer and Dale W. Edgar and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

Edward Raby

39 papers receiving 528 citations

Peers

Edward Raby
Edward Raby
Citations per year, relative to Edward Raby Edward Raby (= 1×) peers Ricardo Wesley Alberca

Countries citing papers authored by Edward Raby

Since Specialization
Citations

This map shows the geographic impact of Edward Raby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward Raby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward Raby more than expected).

Fields of papers citing papers by Edward Raby

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward Raby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward Raby. The network helps show where Edward Raby may publish in the future.

Co-authorship network of co-authors of Edward Raby

This figure shows the co-authorship network connecting the top 25 collaborators of Edward Raby. A scholar is included among the top collaborators of Edward Raby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edward Raby. Edward Raby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yeoh, Daniel K., et al.. (2025). Aminoglycosides: an update on indications, dosing and monitoring. Australian Prescriber. 48(4). 133–138.
2.
Raby, Edward, et al.. (2025). Off-label use of intravenous rifampicin during surgery: analysis of Australian surveillance data and retrospective audit at a tertiary hospital. Antimicrobial Stewardship & Healthcare Epidemiology. 5(1). e100–e100.
3.
Fulurija, Alma, et al.. (2024). Serological Responses to Streptococcus pyogenes Vaccine Candidate Antigens Suggests That Streptococcus dysgalactiae Is the Predominant Cause of Lower Limb Cellulitis. Open Forum Infectious Diseases. 11(6). ofae272–ofae272. 1 indexed citations
4.
Rawlins, Matthew, Steven C. Wallis, Jason A. Roberts, et al.. (2024). Safety, tolerability and pharmacokinetics of subcutaneous cefazolin as an alternative to intravenous administration. Journal of Antimicrobial Chemotherapy. 80(2). 347–353. 2 indexed citations
5.
Smith, Anita, Noor-Ul-Huda Ghori, Mark P. Nicol, et al.. (2024). Optimisation of the sampling method for skin microbiome studies in healthy children: a pilot cohort study. SHILAP Revista de lepidopterología. 3. 1446394–1446394. 4 indexed citations
6.
Lawler, Nathan G., Mark W. Fear, Edward Raby, et al.. (2023). Comprehensive Lipidomic Workflow for Multicohort Population Phenotyping Using Stable Isotope Dilution Targeted Liquid Chromatography-Mass Spectrometry. Journal of Proteome Research. 22(5). 1419–1433. 21 indexed citations
8.
Evans, Tess, Umar Ali, Ryan S. Anderton, et al.. (2023). Lower gut dysbiosis and mortality in acute critical illness: a systematic review and meta-analysis. Intensive Care Medicine Experimental. 11(1). 6–6. 14 indexed citations
9.
Raby, Edward, Fiona Wood, Ranil Coorey, et al.. (2021). An in vitro study into the antimicrobial and cytotoxic effect of Acticoat™ dressings supplemented with chlorhexidine. Burns. 48(4). 941–951. 8 indexed citations
10.
Manning, Laurens, et al.. (2021). Revisiting the inoculum effect for Streptococcus pyogenes with a hollow fibre infection model. European Journal of Clinical Microbiology & Infectious Diseases. 40(10). 2137–2144. 4 indexed citations
11.
Lodge, Samantha, Philipp Nitschke, Torben Kimhofer, et al.. (2021). NMR Spectroscopic Windows on the Systemic Effects of SARS-CoV-2 Infection on Plasma Lipoproteins and Metabolites in Relation to Circulating Cytokines. Journal of Proteome Research. 20(2). 1382–1396. 64 indexed citations
12.
Lawler, Nathan G., Nicola Gray, Torben Kimhofer, et al.. (2021). Systemic Perturbations in Amine and Kynurenine Metabolism Associated with Acute SARS-CoV-2 Infection and Inflammatory Cytokine Responses. Journal of Proteome Research. 20(5). 2796–2811. 79 indexed citations
13.
14.
Ingram, Paul R., Lynn K. Barrett, Edward Raby, et al.. (2020). Laboratory and clinical impacts of an overnight laboratory service. European Journal of Clinical Microbiology & Infectious Diseases. 40(2). 353–359. 2 indexed citations
15.
Kumarasinghe, Sujith Prasad, et al.. (2019). Granular parakeratosis is a reaction pattern in hyperkeratotic flexural erythema. Australasian Journal of Dermatology. 61(2). 159–160. 2 indexed citations
16.
Kumarasinghe, Sujith Prasad, et al.. (2019). Hyperkeratotic flexural erythema responding to amoxicillin–clavulanic acid therapy: Report of four cases. Australasian Journal of Dermatology. 60(4). 311–314. 10 indexed citations
17.
Murphy, Riley, Joshua P. Ramsay, Stanley Pang, et al.. (2019). Multiple introductions of methicillin-resistant Staphylococcus aureus ST612 into Western Australia associated both with human and equine reservoirs. International Journal of Antimicrobial Agents. 54(6). 681–685. 13 indexed citations
18.
Raby, Edward, Fekade B. Sime, Laurens Manning, et al.. (2019). Ceftolozane–tazobactam in an elastomeric infusion device for ambulatory care: an in vitro stability study. European Journal of Hospital Pharmacy. 27(e1). e84–e86. 17 indexed citations
19.
Rawlins, Matthew, Edward Raby, John R. Dyer, et al.. (2018). Pharmacokinetics of Ceftolozane-Tazobactam during Prolonged Intermittent Renal Replacement Therapy. Chemotherapy. 63(4). 203–206. 9 indexed citations
20.
Raby, Edward & John R. Dyer. (2013). Endemic (Murine) Typhus in Returned Travelers from Asia, a Case Series: Clues to Early Diagnosis and Comparison with Dengue. American Journal of Tropical Medicine and Hygiene. 88(4). 701–703. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026